Last updated on February 2019

Randomized Global Phase 3 Study to Evaluate the Impact on NASH With Fibrosis of Obeticholic Acid Treatment


Brief description of study

The primary objectives of this study are to evaluate the effect of Obeticholic Acid treatment compared to placebo on 1) histological improvement and 2) liver-related clinical outcomes in patients with non-cirrhotic nonalcoholic steatohepatitis (NASH) with liver fibrosis.

Clinical Study Identifier: NCT02548351

Find a site near you

Start Over

Fundacion de Investigacion

San Juan, Puerto Rico
1.81miles
  Connect »

Hospital Auxilio Mutuo

San Juan, Puerto Rico
2.47miles
  Connect »

Klinical Investigations Group, LLC

San Juan, Puerto Rico
5.05miles
  Connect »